Green Thumb Industries (GTBIF) Tax Provisions (2019 - 2026)
Green Thumb Industries (GTBIF) posted Tax Provisions of $48.1 million for Q1 2026, up 154.74% on a QoQ basis from -$87.9 million in Q4 2025, and up 53.57% year-over-year from $31.3 million in Q1 2025.
Green Thumb Industries (GTBIF) Tax Provisions (2019 - 2026) Analysis & Trends
Green Thumb Industries' Tax Provisions history runs 8 years deep, the most recent figure standing at $48.1 million for Q1 2026.
- Quarterly Tax Provisions rose 53.57% year-over-year to $48.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.9 million (up 55.56% YoY) and the FY2025 annual result came in at $14.2 million, down 31.68% from the prior year.
- Tax Provisions was $48.1 million for Q1 2026 at Green Thumb Industries, up from -$87.9 million in the prior quarter.
- Across five years, Tax Provisions topped out at $49.1 million in Q3 2025 and bottomed at -$87.9 million in Q4 2025.
- A 5-year average of $15.2 million and a median of $31.9 million in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions soared 141.18% — and 2023, when it tumbled 251.3%.
- Green Thumb Industries' Tax Provisions stood at $40.4 million in 2022, then tumbled by 251.3% to -$61.2 million in 2023, then decreased by 21.41% to -$74.3 million in 2024, then fell by 18.33% to -$87.9 million in 2025, then surged by 154.74% to $48.1 million in 2026.
- Business Quant data shows GTBIF's Tax Provisions at $48.1 million in Q1 2026, -$87.9 million in Q4 2025, and $49.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 48.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.09 Mn |
| Dec 31, 2025 | -87.86 Mn |
| Sep 30, 2025 | 49.12 Mn |
| Jun 30, 2025 | 21.58 Mn |
| Mar 31, 2025 | 31.32 Mn |
| Dec 31, 2024 | -74.25 Mn |
| Sep 30, 2024 | 30.92 Mn |
| Jun 30, 2024 | 31.90 Mn |
| Mar 31, 2024 | 32.15 Mn |
| Dec 31, 2023 | -61.16 Mn |
| Sep 30, 2023 | 34.53 Mn |
| Jun 30, 2023 | 25.77 Mn |
| Mar 31, 2023 | 33.64 Mn |
| Dec 31, 2022 | 40.42 Mn |
| Sep 30, 2022 | 32.97 Mn |
| Jun 30, 2022 | 38.34 Mn |
| Mar 31, 2022 | 31.13 Mn |
| Dec 31, 2021 | -98.15 Mn |
| Sep 30, 2021 | 37.32 Mn |
| Jun 30, 2021 | 30.03 Mn |